The effect of 3 and 6 weeks of aerobic exercise on the growth and inflammatory factors of the liver following the induction of different doses of doxorubicin

Number of pages: 174 File Format: word File Code: 31685
Year: 2013 University Degree: Master's degree Category: Physical Education - Sports
  • Part of the Content
  • Contents & Resources
  • Summary of The effect of 3 and 6 weeks of aerobic exercise on the growth and inflammatory factors of the liver following the induction of different doses of doxorubicin

    Doxorubicin (DOX) is an antibiotic with a wide range of anti-tumor and anti-cancer (anti-neoplastic) functions and has been widely used in the treatment of various cancers since the late 60s. Unfortunately, the clinical use of this highly effective anticancer drug has been limited, and this is due to the severe toxic effects of this drug on some body tissues, including the heart, liver, kidney, and nervous system. The effect of 3 and 6 weeks of aerobic exercise on the growth and inflammatory factors of the liver following the induction of different doses of doxorubicin in male rats. 72 Wistar male rats were randomly divided into two control and training groups. The training group itself was divided into 3 and 6 weeks. The training program included running on the treadmill for 25-54 minutes per day at a speed of 15-20 meters per minute, 5 sessions per week for 3 and 6 weeks. At the end of the training period, the mice of the control and training groups were again randomly divided into subgroups of doxorubicin (10 mg/kg and 20 mg/kg) and saline (0.9%). Both injections were performed 24 hours after the last training session and the rats were killed 24 hours later. The levels of growth and inflammatory factors were measured through the ELISA method. The data were analyzed by one-way analysis of variance and Tukey's post hoc test (LSD) at the P?0.05 level. Induction of doxorubicin (10 and 20 mg/kg) led to the imbalance of growth and inflammatory indicators in the liver. 3 led to a significant increase in IGF-1 and 6 weeks of training led to a significant decrease in IGF-1, a significant increase in IGFBP-3 and IGFBP-3/IGF-1 compared to the control + saline group. Despite this, after 3 weeks of aerobic exercise and DOX injection (10 and 20 mg/kg), all indicators showed a non-significant increase and decrease in the dose of 10 and a significant decrease in IGF-1, IGF-1/IGFBP-3 and IFN-? compared to the control group + doxorubicin 10 or 20 mg/kg. Also, after 6 weeks of aerobic exercise and DOX injection (10 and 20 mg/kg), a significant decrease in IGF-1 and IGF-1/IGFBP-3 and a significant increase in IGFBP-3 and a significant decrease in IGF-1 and IGF-1/IGFBP-3 and IFN-? were observed, respectively, compared to the control group + doxorubicin 10 or 20 mg/kg. On the other hand, there was no significant difference between treatment with doxorubicin 10 and 20 mg/kg. The results suggest that liver protection caused by chronic exercise training in mice treated with DOX is associated with the moderation of growth and inflammatory factors. Introduction

    Cancer is a major public health problem in the United States and many other regions of the world. One in four deaths in the United States is caused by cancer. The American Cancer Society estimates the number of new cancer cases and deaths in the United States each year, and with the most recent cancer incidence data compiled, a total of 1,638,910 new cancer cases and 577,190 cancer deaths occurred in the United States in 2012. During the last 5 years, the rate of cancer prevalence in men has decreased (up to 0.6% per year) and was stable in women, while the cancer mortality rate has decreased by 1.8% per year in men and 1.6% per year in women. Doxorubicin is a chemotherapy drug used to treat many different types of cancer. Its other name is Adriamycin and it belongs to the family of anthracycline antibiotics and is made from Streptomyces bacteria [2]. Oxidative stress and free radical formation, which involves the reaction of doxorubicin with iron, are believed to play a critical role in the mechanism of doxorubicin toxicity.  Doxorubicin is significantly toxic to many tissues and organs, but its heart and liver toxicity is one of the limiting factors of this drug in cancer treatment [137]. Therefore, adopting any non-pharmacological strategy, including regular aerobic activity, can have a significant effect on preventing many problems in the body's systems. The current study seeks to find a strategy to reduce the side effects caused by the use of doxorubicin, and in this regard, to investigate the effect of 3 and 6 weeks.The present study seeks to find a strategy to reduce the side effects caused by the use of doxorubicin, and in this regard, investigates the effect of 3 and 6 weeks of aerobic exercise on growth and inflammatory factors following hepatotoxicity caused by the induction of different doses of this drug.

    1-2. Statement of the problem

    According to the report of the American Health Association, 7.6 million people died of cancer in 2007. Therefore, in recent years, extensive efforts have been made by researchers to treat or slow down the growth of cancer cells. Doxorubicin (DOX) [1] is an antibiotic with a wide range of anti-tumor and anti-cancer (anti-neoplastic) [3,28,46,132,167,172] and has been widely used in the treatment of various cancers since the late 60s [4]. Unfortunately, the clinical use of this highly effective anticancer drug has been limited, and this is due to the severe toxic effects of this drug on some body tissues, including the heart, liver, kidney, and nervous system. It is believed that several molecular mechanisms, including the production of reactive oxygen species [2] (ROS) [138,5,47,174] and the stimulation of cell death [3] (apoptosis) [57,92] play a pivotal role in this cytotoxic process. In this regard, significant efforts have been made by researchers in the fields of medicine [46,132,172] and sports [3,4,167,93] to develop strategies to prevent toxicity caused by DOX, especially in heart tissue. In a study, Babaei et al.[132] reported the protective effect of morphine in DOX-induced cardiotoxicity. Other researchers also showed the protective effect of tetradrine [4] and amifostine [5] against cardiac damage and cardiotoxicity caused by DOX [46, 172]. While few studies have been conducted on the toxic effect of DOX in the liver tissue.

             Researchers investigated several indicators related to the growth and spread of cancer cells. The IGF system plays a critical role in cell proliferation. It includes IGF-1 and IGF-2 and families of IGF-binding proteins (IGFBP) that specifically bind to IGF [178]. Studies indicate that IGFBP dysregulation occurs in complications such as neuroblastoma [6], nephroblastoma [7] and acute lymphoblastic leukemia [8] [178]. Therefore, there is growing evidence that the IGF system is used as a panel of tumor markers for histological diagnosis in various cancer-related diseases. In this regard, it was reported that insulin-like growth factor [9] (IGF-1) and IGF-binding protein-3 [10] IGFBP-3) and IGF-binding protein-1 [11] IGFBP-1) are associated with increased risk of breast cancer in premenopausal women [133]. Recently, the results of the analysis of 17 studies conducted in this field show that the levels of IGF-1 are positively related to the estrogen receptor regardless of the menopausal status [132]. However, it has not been determined whether the implementation of sports training can affect the levels of IGF-1 and proteins connected to it.  In addition, it is not known what effect induction of DOX with two doses of 10 and 20 mg per kilogram of body weight has on these growth factors in liver tissue and whether performing 3 and 6 weeks of aerobic exercises before the induction of these doses can affect the process of changes in these indicators? In spite of the mentioned cases, although in young women, it has been determined that strength training reduces IGF-1 [139]. But there are very few longitudinal studies on the effects of IGF-1 protein training. We hypothesize that doing exercise will reduce IGF-1, increase the levels of proteins connected to it and reduce the ratio of IGF-1 to IGFBP-3, and in this way will reduce the risks associated with cancer. Also, reports indicate that inflammation through mechanisms such as the production of cytokines and growth factors and the production of ROS and the accumulation of reactive nitrogen species[12] (RNS) may play a role in the generation of cancer cells. On the other hand, researchers reported that performing physical activity in a proper way inhibits inflammatory indicators caused by chronic diseases, such as interleukins and interferon gamma, and in this way maintains and restores the homeostasis of various body systems. However, the preventive effect of different training periods (3 and 6 weeks) on the changes, especially following the induction of DOX and oxidative stress and cardiotoxicity caused by it, has not been investigated so far.

  • Contents & References of The effect of 3 and 6 weeks of aerobic exercise on the growth and inflammatory factors of the liver following the induction of different doses of doxorubicin

    List:

    First chapter

    1-1. Introduction. 2

    1-2. State the problem. 3

    1-3. The importance and necessity of research. 6

    1-4. Objectives of the research: 9

    1-4-1. general purpose 9

    1-4-2. Special objectives. 9

    1-5. Research hypotheses. 9

    1-6. Definition of research words and terms. 10

    Chapter Two

    2-1. Introduction. 14

    2-2.  Theoretical foundations of research. 14

    2-2-1. Anthracyclines and history. 14

    2-2-2. Doxorubicin as a therapeutic agent. 17

    2-2-3. Unintended toxicity of doxorubicin. 20

    2-2-4. Unintended toxicity of doxorubicin in the liver. 23

    2-2-5. Anatomy and physiology of liver tissue. 26

    2-2-6. Cancer in the liver. 28

    2-2-7. Mechanism of inflammation in cancer. 29

    2-2-8. Structure and physiology of inflammatory factors. 31

    2-2-8-1.  Interleukin 10 (IL-10). 31

    2-2-8-2. Interferon gamma (IFN?). 33

    2-2-9. Growth apparatus. 35

    2-2-10. IGF binding proteins. 41

    2-3. Research background. 43

    2-3-1. Studies of doxorubicin in non-sports and sports 43

    Chapter 3

    3-1. Introduction. 56

    3-2. Research method. 56

    3-3. Research subjects. 56

    3-4. Research variables. 59

    3-4-1. independent variables. 59

    3-4-2. dependent variable. 59

    3-5. Feeding and animal keeping environment: 59

    3-6. Tools used in the research: 60

    3-7. The training program of the subjects. 61

    3-8. How to prepare and inject doxorubicin. 63

    3-9. Tissue sampling and laboratory analysis. 64

    3-10. Information analysis method. 65

    Chapter Four

    4-1. Introduction. 67

    4-2. Descriptive data analysis. 67

    4-2-1. Insulin-like factor (IGF-1). 67

    4-2-2. IGF-1 binding protein-1 (IGFBP-1). 70

    4-2-3. IGF-binding protein-3 (IGFBP-3). 73

    4-2-4. Ratio of IGF-1 to IGFBP-3. 75

    4-2-5.  Interferon gamma. 78

    4-2-6. Interleukin 10 (IL-10). 80

    4-3. Testing research hypotheses. 82

    4-3-1. Test of the first hypothesis. 83

    4-3-2. Test of the second hypothesis. 85

    4-3-3. Test of the third hypothesis. 86

    4-3-4. The fourth hypothesis test. 88

    4-3-5. Test of the fifth hypothesis. 90

    4-3-6. Sixth hypothesis test. 91

    Chapter Five

    5-1. Introduction. 95

    5-2. Summary of the research. 95

    5-3. Discussion and review. 100

    5-3-2. Investigation of IGFBP3. 105

    5-3-3. Review of IL-10. 107

    5-3-4. Investigating changes in INF-?. 109

    5-4. conclusion 112

    5-5. Research limitations. 113

    5-6. Research proposals. 113

    5-6-1. Suggestions arising from research. 113

    5-6-2. Suggestions for future researchers. 114

    Resources. 116

    Appendix. 125

    Appendix A. 125

     

    Source:

    Eddington and Edgerton, translated by Nikbakht, Hojjat A., (1380): "Biology of physical activity", organization for the study and compilation of humanities books of universities (Samt).

    Ahmedin Jemal DVM.(2012) A Cancer Journal for Clinicians. American Cancer Society;(62):10-29.

    Adam J. Chicco, Carole M. Schneider, and Reid Hayward(2005) Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol 289: R424–R431

    Ana R. Lehenbauer Ludke, Abd Al-Rahman S. Al-Shudiefat, Sanjiv Dhingra, Davinder S. Jassal, and Pawan K. Singal(2009) A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity Can. J. Physiol. Pharmacol. 87: 756–763.

    Ascensao A, Magalhaes J, Soares J, Ferreira R, Neuparth M, Marques F, Oliveira J, and Duarte J. (2005) Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol 100: 451–460.

    Andrea Y. Arikawa, Mindy S. Kurzer, William Thomas, and Kathryn H. Schmitz. No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2010; 19(11): 2987–2990.

    Andrea Y. Arikawa, Mindy S.Kurzer, William Thomas, and Kathryn H. Schmitz. No effect of exercise on insulin-like growth factor (IGF)-1, insulin and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2010; 19(11): 2987–2990.

    Adams, G.; Stratford, I. Bioreductive drugs for cancer therapy: the search for tumor specificity. Int. J. Radiat. Oncol. Biol. Phys. 1994, 29, 231-238.

    American Liver Foundation. The Progression of Liver Disease. 2013.

    American Cancer Society. Adult Primary Liver Cancer Treatment. 2012.

    Abbas A.B.; Lichtman A.H. "Ch.2 Innate Immunity". In Saunders (Elsevier). Basic Immunology. Functions and disorders of the immune system; (2009).

    Anita G?lvez, José Miguel Eltit, Paula Ocaranza. IGF-1 Regulates Apoptosis of Cardiac Myocyte Induced by Osmotic-Stress. Chemical and Pharmaceutical Sciences.(2004);43-78.

    Adelheid Soubry, Dora Il'yasova, Rebecca Sedjo, Frances Wang, Tim Byers, Clifford Rosen.  Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps.(2011);26:126-198.

    Ana S. Martins, Carlos Mackintosh, David Herrero Mart?n, Maria Campos, Teresa Hern?ndez, Jose-Luis Ord??ez and Enrique de Alava. Insulin-Like Growth Factor I Receptor Pathway Inhibition by ADW742, Alone or in Combination with Imatinib, Doxorubicin, or Vincristine, Is a Novel Therapeutic Approach in Ewing Tumor. Cancer Res. 2006 ;12: 35-58.

    Arikawa AY, Kurzer MS, Thomas W, Schmitz KH. No effect of exercise on insulin-like growth factor-I, insulin, and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2987-90.

    A M M Haydon1, R J MacInnis2, D R English3, H Morris4, G G Giles3. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer. Colorectal cancer. 2006;55:689-694.

    Aline Bolpetti, Jo?o S Silva, Luisa L Villa and Ana Paula Lepique.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth. BMC Immunology 2010, 11:27.

    Bonfante, V; Bonadonna, G; Villani, F; Martini, A (1980). "Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasia". Recent results in cancer research 74: 192–9

    Breslow, N.; Ou, S.; Beckwith, M.; Haase, G.; Kalapurakal, J.; Ritchey, M.; Shamberger, R.; Thomas, P.; D'Angio, G.; Green, D. Doxorubicin for Favorable Histology, Stage II-III Wilms Tumor Results from the National Wilms Tumor Studies. Cancer, 2004,101, 1072-1080.

    Box, V. The intercalation of DNA double helices with doxorubicin and nagalomycin. J. Mol. Graph Mod., 2007, 26, 14-19.

    Begleiter, A.; Leith, M. Activity of quinine alkylating agents in quinine resistant cells. Cancer Res., 1990, 50, 2872-2876.

    Bernardi, P.; Scorrano, L.; Colonna, R.; Petronilli, V.; Di Lisa, F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur. J. Biochem., 1999, 264, 687-701.

    Bien, S.; Ritter, C.; Gratz, M.; Sperker, B.; Sonnemann, J.; Beck, J.; Kroemer, H. Nuclear factor-B mediates up-regulation of cathepsin B by doxorubicin in tumor cells. Mol. Pharmacol., 2004, 65, 1092-1102.

    Bien, S.; Ritter, C.; Gratz, M.; Sperker, B.; Sonnemann, J.; Beck, J.; Kroemer, H. Nuclear factor-B mediates up-regulation of cathepsin B by doxorubicin in tumor cells. Mol. Pharmacol., 2004, 65, 1092-1102. Borsellino N, Crescimanno M, Flandina C, Leonardi V, Rausa L, D'Alessandro N. Antiproliferative and chemomodulatory effects of interferon-gamma on doxorubicin-sensitive and -resistant tumor cell lines. Anticancer Drugs. 1993 Apr;4(2):265-72.

    Beech, D. J., Perer, E., Helms, J., Gratzer, A. & Deng, N.

The effect of 3 and 6 weeks of aerobic exercise on the growth and inflammatory factors of the liver following the induction of different doses of doxorubicin